IRIS UniCatt

Fargnoli, Maria Concetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.299
NA - Nord America 2.292
EU - Europa 1.386
SA - Sud America 535
AF - Africa 84
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 6.604
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.213
SG - Singapore 1.258
CN - Cina 485
BR - Brasile 462
SE - Svezia 301
IT - Italia 234
DE - Germania 209
IE - Irlanda 120
IN - India 114
GB - Regno Unito 105
VN - Vietnam 97
FR - Francia 95
ID - Indonesia 85
FI - Finlandia 65
RU - Federazione Russa 63
HK - Hong Kong 62
CA - Canada 40
BD - Bangladesh 34
AR - Argentina 32
AT - Austria 30
KR - Corea 29
BE - Belgio 27
JP - Giappone 26
MX - Messico 26
CI - Costa d'Avorio 25
PL - Polonia 23
CZ - Repubblica Ceca 21
ZA - Sudafrica 20
IQ - Iraq 19
TR - Turchia 19
ES - Italia 18
NL - Olanda 15
PK - Pakistan 13
EC - Ecuador 12
UA - Ucraina 12
CH - Svizzera 11
KE - Kenya 10
RO - Romania 10
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
EG - Egitto 7
PE - Perù 7
VE - Venezuela 7
MA - Marocco 6
CO - Colombia 5
JM - Giamaica 5
JO - Giordania 5
LT - Lituania 5
SA - Arabia Saudita 5
IL - Israele 4
KZ - Kazakistan 4
MY - Malesia 4
AL - Albania 3
CL - Cile 3
DK - Danimarca 3
DZ - Algeria 3
GH - Ghana 3
IR - Iran 3
NO - Norvegia 3
PY - Paraguay 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
AU - Australia 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
BO - Bolivia 2
EU - Europa 2
GR - Grecia 2
GT - Guatemala 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
UY - Uruguay 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
CG - Congo 1
CR - Costa Rica 1
EE - Estonia 1
ET - Etiopia 1
GM - Gambi 1
HU - Ungheria 1
IM - Isola di Man 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MM - Myanmar 1
MN - Mongolia 1
NG - Nigeria 1
NI - Nicaragua 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
Totale 6.601
Salva come PNG Salva come JPEG
Città #
Singapore 601
Chandler 420
Ashburn 202
Dallas 159
Beijing 134
Dublin 120
Ann Arbor 98
New York 89
Jakarta 80
Hefei 79
Los Angeles 65
Hyderabad 64
Boston 62
Hong Kong 62
Milan 56
Bremen 54
Princeton 52
San Mateo 46
Rome 43
Helsinki 41
São Paulo 40
Frankfurt am Main 39
Munich 38
Moscow 36
Wilmington 32
Chicago 29
Seoul 29
Ho Chi Minh City 28
Kent 26
Abidjan 25
Brussels 24
Hanoi 24
Nuremberg 24
London 23
North Bergen 22
Tokyo 22
The Dalles 19
Houston 17
Woodbridge 17
Brooklyn 16
Vienna 16
Brno 15
Washington 15
Cattolica 14
Montreal 13
Poplar 13
Portsmouth 12
Seattle 12
Atlanta 11
Falkenstein 11
Jacksonville 11
Mexico City 11
Stockholm 11
Turku 11
Wroclaw 11
Belo Horizonte 10
Düsseldorf 10
Nairobi 10
Nanjing 10
Paris 10
Rio de Janeiro 10
San Francisco 10
Santa Clara 10
Warsaw 10
Baghdad 9
Brasília 9
Denver 9
Johannesburg 9
Lappeenranta 9
Orem 9
Redwood City 9
Ribeirão Preto 9
Toronto 9
Amsterdam 8
Chennai 8
Curitiba 8
Manchester 8
Mountain View 8
New Delhi 8
Phoenix 8
Tashkent 8
Bexley 7
Ankara 6
Birmingham 6
Dearborn 6
Fairfield 6
Monza 6
Mumbai 6
Norwalk 6
Quito 6
Amman 5
Campinas 5
Da Nang 5
Erbil 5
Guarulhos 5
Kingston 5
Lauterbourg 5
Lima 5
Newark 5
Ottawa 5
Totale 3.584
Salva come PNG Salva come JPEG
Nome #
Real-life efficacy and safety of ingenol mebutate for the treatment of actinic keratosis of the face and scalp: A single arm retrospective study 177
A new dermoscopic algorithm for the differential diagnosis of facial lentigo maligna and pigmented actinic keratosis 144
Cutaneous squamous cell carcinoma. Italian guidelines by SIDeMaST adapted to and updating EADO/EDF/EORTC guidelines 138
Real-world evidence of biologic treatments in moderate–severe psoriasis in Italy: Results of the CANOVA (EffeCtiveness of biologic treAtmeNts for plaque psOriasis in Italy: An obserVAtional longitudinal study of real-life clinical practice) study 112
Management of cutaneous melanoma: Comparison of the leading international guidelines updated to the 8th American Joint Committee on Cancer staging system and workup proposal by the Italian Society of Dermatology 108
Pruritus characteristics in a large Italian cohort of psoriatic patients 107
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis 106
Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation 105
Sclerosing nevus with pseudomelanomatous features: dermoscopic and confocal aspects 103
A real-world economic analysis of biologic therapies for moderate-to-severe plaque psoriasis in Italy: results of the CANOVA observational longitudinal study 99
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: results from extension phase of the SUPREME study 95
Characterization of melanoma susceptibility genes in high-risk patients from Central Italy 91
Expression of IL-23/Th17-related cytokines in basal cell carcinoma and in the response to medical treatments 91
Molecular genetics of cutaneous squamous cell carcinoma: perspective for treatment strategies 90
European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention 90
A 52-week update of a multicentre Italian real-world experience on effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis 89
Disease Severity Is Associated with Alexithymia in Patients with Atopic Dermatitis 87
Advanced Cutaneous Squamous Cell Carcinoma: Italian Multicentric Retrospective Analysis of Patient Profiles and Therapeutic Approaches 86
Clinical Characteristics of an Italian Patient Population with Advanced BCC and Real-Life Evaluation of Hedgehog Pathway Inhibitor Safety and Effectiveness 86
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis 86
Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study 85
Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study 84
Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation 83
European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022 81
"Your Skin Tells You" Campaign for Keratinocyte Cancers: When Individuals' Selection Makes the Difference 81
European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics – Update 2019 81
Psoriasis and its management in women of childbearing age: Tools to increase awareness in dermatologists and patients 81
European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma—update 2023 80
Assessing the beneficial impact of a patient support program in secukinumab-treated patients with psoriasis in italy 80
Coding and noncoding somatic mutations in candidate genes in basal cell carcinoma 79
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry 78
Efficacy and safety of Vismodegib treatment in patients with advanced basal cell carcinoma and multiple comorbidities 77
Heterogeneity of BRAF, NRAS, and TERT Promoter Mutational Status in Multiple Melanomas and Association with MC1R Genotype: Findings from Molecular and Immunohistochemical Analysis 76
Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility 76
Treatment adherence with diclofenac 3% gel among patients with multiple actinic keratoses: an integrated low-intensity intervention program versus standard-of-care 76
Clinical determinants of complete response to vismodegib in locally advanced basal cell carcinoma: a multicentre experience 76
Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma 75
5-aminolaevulinic acid patch photodynamic therapy for the treatment of actinic keratoses: preliminary results from an italian study in the real-life setting 75
The dynamics of circulating tumour DNA (ctDNA) during treatment reflects tumour response in advanced melanoma patients 75
Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study 74
ΜelanoQ: A Consensus Questionnaire of Standardized Epidemiologic and Clinical Variables for Melanoma Risk Assessment by the MelaNostrum Consortium 74
Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus Recommendations 74
A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16-week real-life experience during the COVID-19 pandemic 74
Molecular alterations in basal cell carcinoma subtypes 74
Position statement on classification of basal cell carcinomas. Part 1: unsupervised clustering of experts as a way to build an operational classification of advanced basal cell carcinoma based on pattern recognition 74
Self-Assessment Questionnaire on Patient-Physician Concordance on Nevus Self-Count and Models Development to Predict High-Risk Phenotype >50 Nevi 73
Real-World Apremilast Use for Treatment of Plaque Psoriasis in Italy: Patient Perspective, Characteristics, and Clinical Outcomes from the DARWIN Study 73
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment – Update 2019 73
Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma 73
Novel MAPK/AKT-impairing germline NRAS variant identified in a melanoma-prone family 73
European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment-Update 2023 71
Comment on ‘Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines’ 71
Successful response of upadacitinib in different clinical phenotypes of atopic dermatitis 71
"Your Skin Tells You" Campaign for Keratinocyte Cancers: When Individuals' Selection Makes the Difference 70
Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian study 70
Efficacy and Safety of bimekizumab in elderly patients: real-world multicenter retrospective study–IL PSO (Italian Landscape Psoriasis) 69
Satisfaction and attitudes toward systemic treatments for psoriasis: A cross-sectional study 69
Position statement on classification of basal cell carcinomas. Part 2: EADO proposal for new operational staging system adapted to basal cell carcinomas 68
Patient satisfaction with calcipotriol/betamethasone dipropionate cutaneous foam for the treatment of plaque psoriasis: The LION real-life multicenter prospective observational cohort study 68
Long-term efficacy and safety of daylight photodynamic therapy with methyl amninolevulinate for actinic keratosis of the face and scalp 66
Corrigendum: “Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma” (European Journal of Cancer (2021) 157 (250–258), (S0959804921005360), (10.1016/j.ejca.2021.08.018)) 65
Mycosis fungoides: creation of a prospective, interdisciplinary and multicenter study in central Italy 63
Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study 63
Bimekizumab for the Treatment of Plaque Psoriasis with Involvement of Genitalia: A 16-Week Multicenter Real-World Experience - IL PSO (Italian Landscape Psoriasis) 61
Beneficial effects of upadacitinib on alopecia areata associated with atopic dermatitis: A multicenter retrospective study 61
Response to: Comment on ‘Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines’ 61
Correction to: Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study (Archives of Dermatological Research, (2022), 314, 6, (593-603), 10.1007/s00403-021-02243-w) 60
The role of insomnia in the vulnerability to depressive and anxiety symptoms in atopic dermatitis adult patients 60
Telomeres and telomerase in cutaneous squamous cell carcinoma 60
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022 58
Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline – Update 2022 57
The Risk of Candidiasis During Treatment with Bimekizumab for the Management of Plaque Psoriasis: A 16-Week Multicenter Real-World Experience - IL PSO (Italian Landscape Psoriasis) 57
AtopyReg®: the prospective Italian patient registry for moderate to severe atopic dermatitis in adults by SIDeMaST 57
Dermoscopic similarity is an independent predictor of BRAF mutational concordance in multiple melanomas 57
Contribution of common genetic variants to familial aggregation of disease and implications for sequencing studies 57
Italian expert consensus paper on the management of patients with actinic keratoses 57
The association between COVID-19 lockdowns and melanoma diagnosis and thickness: A multicenter retrospective study from Europe 55
Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia 55
Italian National Registry of Alopecia Areata: an epidemiological study of 699 Italian patients 52
Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement 51
Assessing a measure for Quality of Life in patients with severe Alopecia Areata: a multicentric Italian study 50
Effectiveness of tildrakizumab 200 mg: an Italian multicenter study 49
Update on the Management of Pediatric Psoriasis: An Italian Consensus 49
Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experience 47
High- and intermediate-risk susceptibility variants in melanoma families from the Mediterranean area: A multicentre cohort from the MelaNostrum Consortium 46
Prevalence and risk factors of actinic keratosis in patients attending Italian dermatology clinics 40
Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls 37
A long-term real-world safety study of guselkumab in patients with psoriasis who have infectious comorbidities, malignancies or heart disease: The EARLY study 22
Effectiveness, speed of action and safety of brodalumab in elderly psoriasis patients: a multicenter real-world study–IL PSO (Italian Landscape Psoriasis) 22
BRodalumab effectiveness in psoriatic patients that experienced anti-IL17 Intra-Class failure: a multicentre, retrospective study (BRIC - Study) IL-PSO (Italian Landscape Psoriasis) 19
Use of upadacitinib in the treatment of moderate to severe atopic dermatitis: patient profiling, dose selection, and therapy modulation, what does real-life teach us? 17
Effectiveness and safety of baricitinib in severe alopecia areata: 48-week results 14
Gender Influence on Bimekizumab Response in Patients with Psoriasis: Results of a Real-World Multicenter Retrospective Study—IL PSO (Italian Landscape PSOriasis) 14
Predictive Factors for Super Responder Status and Long-Term Effectiveness of Guselkumab in Psoriasis: A Multicenter Retrospective Study 14
Effectiveness of Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: A Retrospective, Real-World Multicenter Study with a Focus on Obese and Multi-Failure Patients—IL PSO (Italian Landscape Psoriasis) 13
Super Responder Profile Under Bimekizumab Treatment in Moderate-to-Severe Psoriasis: A Short Term Real-Life Observation—IL PSO (Italian Landscape Psoriasis) 10
Totale 6.721
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.178
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.178
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021118 0 0 0 0 0 7 16 44 9 7 29 6
2021/2022445 15 8 8 17 29 8 1 66 32 35 111 115
2022/20231.023 111 134 75 184 77 124 29 86 146 16 31 10
2023/2024751 26 184 52 54 47 104 55 10 15 27 88 89
2024/20251.762 41 28 107 56 151 115 60 77 268 206 363 290
2025/20262.378 604 226 238 497 771 42 0 0 0 0 0 0
Totale 6.721